Journal of vascular surgery cases and innovative techniques
August 24, 2026 · via Europe PMC
Recurrent thoracic aortic stent graft thrombosis.
Valdes YC, Khan F, Abbruzzese T.
AI summary — for doctors, generated from the abstract only
Thoracic stent graft thrombosis can recur late and cause visceral embolization, even after treatment of a non-traumatic aortic thrombus.
What was studied
Case report of a patient with recurrent thoracic aortic stent graft thrombosis and mesenteric thrombosis, treated with repeat stent grafting and SMA thrombectomy.
Key findings
- Post-op imaging showed good graft position without endoleak.
- Initial hematologic workup, including JAK2 V617F and PNH testing, was unrevealing but incomplete due to loss of follow-up.
- It is a rare late occurrence.
Clinical relevance
Aortic thrombus can recur, so surveillance and thrombophilia evaluation matter.
Who should care
Limitations
A single case with an incomplete workup.
Complete a hematologic evaluation and follow patients with thoracic aortic thrombus closely.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Thoracic aortic mural thrombus is an uncommon but clinically significant source of visceral and peripheral embolization. Endovascular stent grafting is an established treatment; however, recurrent thrombosis within the stent graft in the absence of endoleak, stent migration, technical failure, or hypercoagulable states is rare and poorly understood. We present the case of a 66-year-old man with previous descending thoracic aortic stent graft placement who presented 5 years after the thoracic endovascular aortic repair with epigastric pain and was found to have recurrent aortic and mesenteric thrombosis. He underwent repeat endovascular stent grafting and superior mesenteric artery thrombectomy. Postoperative imaging demonstrated appropriate stent graft position without endoleak or mechanical complication. An initial hematologic evaluation, including Janus kinase 2 V617F mutation testing and paroxysmal nocturnal hemoglobinuria flow cytometry, was unrevealing, although the workup was incomplete due to loss of follow-up. This case highlights the rare occurrence of late thoracic endograft thrombosis following treatment of nontraumatic descending thoracic aortic thrombus.
DOI
10.1016/j.jvscit.2026.102470
PMID
42828113
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed